ArticleCancer management and research2020

Targeted Inhibition of CCL22 by miR-130a-5p Can Enhance the Sensitivity of Cisplatin-Resistant Gastric Cancer Cells to Chemotherapy.

Qing-Liang Fang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.